Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis

Pathology and Oncology Research

Volumn 20, Issue 1, 2014, Pages 119-129

  Lokamani, Ilambarthi ^a   Looi, Mee Lee ^a,d   Md Ali, Siti Aishah ^b   Mohd Dali, Ahmad Zailani Hatta ^b   Ahmad Annuar, Muhammad Azrif ^c   Jamal, Rahman ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^d TAYLOR S UNIVERSITY   (Malaysia)

Author keywords

2D DIGE; Ceruloplasmin; Cervical neoplasia; Gelsolin; Proteomics

Indexed keywords

CD5 ANTIGEN; CERULOPLASMIN; COMPLEMENT FACTOR H; GELSOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; BLOOD CLOTTING; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID TRANSPORT; FEMALE; HORMONE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IRON TRANSPORT; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UTERINE CERVIX CANCER; VALIDATION PROCESS;

CERULOPLASMIN; DISEASE PROGRESSION; FEMALE; GELSOLIN; HUMANS; IMMUNOHISTOCHEMISTRY; NF-KAPPA B; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UTERINE CERVICAL NEOPLASMS;

EID: 84895875044     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-013-9670-9     Document Type: Article

References (59)

1. Fung ET (2010) A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance. Clin Chem 56:327-329
2. Teramoto R, Minagawa H, Honda M, Miyazaki K, Tabuse Y et al (2008) Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning. Biochimica et Biophysica Acta - Proteins and Proteomics 1784:764-772
3. Zhou G, Li H, DeCamp D, Chen S, Shu H et al (2002) 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics : MCP 1:117-124
4. Katayama M, Nakano H, Ishiuchi A, Wu W, Oshima R et al (2006) Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surg Today 36:1085-1093 (Pubitemid 44819452)
5. Murphy L, Henry M, Meleady P, Clynes M, Keenan J (2008) Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1784:1184-1191
6. Orenes-Pinero E, Corton M, Gonzalez-Peramato P, Algaba F, Casal I et al (2007) Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. J Proteome Res 6:4440-4448 (Pubitemid 350158519)
7. Kakisaka T, Kondo T, Okano T, Fujii K, Honda K et al (2007) Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B 852:257-267 (Pubitemid 46830120)
8. Arnouk H, Merkley MA, Podolsky RH, Stoppler H, Santos C et al (2009) Characterization of molecular markers indicative of cervical cancer progression. Proteomics Clin Appl 3:516-527
9. Jacobs JM, Adkins JN, Qian WJ, Liu T, Shen Y et al (2005) Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res 4:1073-1085 (Pubitemid 41208665)
10. Richart RM (1995) Screening. The next century. Cancer 76:1919-1927
11. Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12:186-192
12. Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J et al (2004) Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 291:2100-2106 (Pubitemid 38580153)
13. Huang HL, Stasyk T, Morandell S, Dieplinger H, Falkensammer G et al (2006) Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 27:1641-1650
14. Watari H, Ohta Y, Hassan MK, Xiong Y, Tanaka S et al (2008) Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Gynecol Oncol 108:527-532
15. Abdul-Rahman PS, Lim BK, Hashim OH (2007) Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods. Electrophoresis 28:1989-1996 (Pubitemid 47040404)
16. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW et al (2005) Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecol Oncol 99:26-35 (Pubitemid 41354579)
17. Lin YW, Lai HC, Lin CY, Chiou JY, Shui HA et al (2006) Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. Int J Gynecol Cancer 16:1216-1224
18. Lee KH, Yim EK, Kim CJ, Namkoong SE, Um SJ et al (2005) Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol 98:45-53
19. Yim EK, Lee KH, Namkoong SE, Um SJ, Park JS (2006) Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells. Cancer Lett 235:209-220
20. Koya RC, Fujita H, Shimizu S, Ohtsu M, Takimoto M et al (2000) Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J Biol Chem 275:15343-15349 (Pubitemid 30337262)
21. Li Y, Qu P, Wu L, Li B, Du H et al. (2011) Api6/AIM/Spα/CD5L Overexpression in alveolar type II epithelial cells induces spontaneous lung adenocarcinoma. Cancer Res 71(16):5488-5499
22. Sun HQ, Yamamoto M, Mejillano M, Yin HL (1999) Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 274:33179-33182 (Pubitemid 129511609)
23. Fujita H, Okada F, Hamada J, Hosokawa M, Moriuchi T et al (2001) Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int J Cancer 93:773-780 (Pubitemid 32756745)
24. Bucki R, Levental I, Kulakowska A, Janmey PA (2008) Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci 9:541-551
25. Yin HL, Kwiatkowski DJ, Mole JE, Cole FS (1984) Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 259:5271-5276 (Pubitemid 14140637)
26. Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB (1999) Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res Treat 55:179-188 (Pubitemid 29389580)
27. Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C et al (2007) Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro. Cancer Lett 255:57-70 (Pubitemid 47212607)
28. De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J et al (2002) Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J 21:6781-6790 (Pubitemid 36014550)
29. Sun H, Lin K, Yin HL (1997) Gelsolin modulates phospholipase C activity in vivo through phospholipid binding. J Cell Biol 138:811-820 (Pubitemid 27365044)
30. Singh SS, Chauhan A, Murakami N, Chauhan VP (1996) Profilin and gelsolin stimulate phosphatidylinositol 3-kinase activity. Biochemistry 35:16544-16549 (Pubitemid 27020496)
31. Gangadharan B, Antrobus R, Dwek RA, Zitzmann N (2007) Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem 53:1792-1799 (Pubitemid 47509672)
32. Sarrias MR, Rosello S, Sanchez-Barbero F, Sierra JM, Vila J et al (2005) A role for human Sp alpha as a pattern recognition receptor. J Biol Chem 280:35391-35398 (Pubitemid 41532728)
33. Gray J, Chattopadhyay D, Beale GS, Patman GL, Miele L et al (2009) A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. BMC Cancer 9:271
34. Rutkowski MJ, Sughrue ME, Kane AJ, Ahn BJ, Fang S et al (2010) The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res 59:897-905
35. Rutkowski MJ, Sughrue ME, Kane AJ, Mills SA, Parsa AT (2010) Cancer and the complement cascade. Mol Cancer Res 8:1453-1465
36. Ajona D, Castano Z, Garayoa M, Zudaire E, Pajares MJ et al (2004) Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res 64:6310-6318 (Pubitemid 39129436)
37. Cheng Z, Corey MJ, Parepalo M, Majno S, Hellwage J et al (2005) Complement Factor H as a marker for detection of bladder cancer. Clin Chem 51(5):856-863 (Pubitemid 40577922)
38. Junnikkala S, Hakulinen J, Jarva H, Manuelian T, Bjorge L et al (2002) Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells. Br J Cancer 87:1119- 1127
39. Kinders R, Jones T, Root R, Bruce C, Murchison H et al (1998) Complement factor H or a related protein is a marker for transitional cell cancer of the bladder. Clin Cancer Res 4:2511-2520 (Pubitemid 28477919)
40. Bradley DT, Zipfel PF, Hughes AE (2011) Complement in age-related macular degeneration: a focus on function. Eye (Lond) 25:683-693
41. Ambrus JL Jr, Peters MG, Fauci AS, Brown EJ (1990) The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. J Immunol 144:1549- 1553
42. Doustjalali SR, Yusof R, Yip CH, Looi LM, Pillay B et al (2004) Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors. Electrophoresis 25:2392 -2401
43. Bloomston M, Zhou JX, Rosemurgy AS, Frankel W, Muro-Cacho CA et al (2006) Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res 66:2592-2599
44. Seriramalu R, Pang WW, Jayapalan JJ, Mohamed E, Abdul-Rahman PS et al (2010) Application of champedak mannose-binding lectin in the glycoproteomic profiling of serum samples unmasks reduced expression of alpha-2 macroglobulin and complement factor B in patients with nasopharyngeal carcinoma. Electrophoresis 31:2388-2395
45. Huang X (2008) Does iron have a role in breast cancer? Lancet Oncol 9:803-807
46. Liehr JG, Jones JS (2001) Role of iron in estrogen-induced cancer. Curr Med Chem 8:839-849 (Pubitemid 32427912)
47. Raju KS, Alessandri G, Ziche M, Gullino PM (1982) Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst 69:1183-1188 (Pubitemid 13254912)
48. Coates RJ, Weiss NS, Daling JR, Rettmer RL, Warnick GR (1989) Cancer risk in relation to serum copper levels. Cancer Res 49:4353-4356 (Pubitemid 19207286)
49. Pejovic M, Djordjevic V, Ignjatovic I, Stamenic T, Stefanovic V (1997) Serum levels of some acute phase proteins in kidney and urinary tract urothelial cancers. Int Urol Nephrol 29:427-432 (Pubitemid 27496167)
50. Doustjalali SR, Yusof R, Govindasamy GK, Bustam AZ, Pillay B et al (2006) Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest 53:20-28
51. Onizuka K, Migita S, Yamada H, Matsumoto I (1999) Serum protein fractions in patients with laryngeal cancer undergoing radiation therapy. Possibility as a prognostic factor. Fukuoka Igaku Zasshi 90:46-58
52. Sampson MT, Kakkar AK (2002) Coagulation proteases and human cancer. Biochem Soc Trans 30:201-207
53. Dolcet X, Llobet D, Pallares J, Matias X (2005) NF-kB in development and progression of human cancer. Virchows archiv 446:8
54. Escarcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A (2007) The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol) 19:154-161 (Pubitemid 46172840)
55. Persichini T, Maio N, di Patti MC, Rizzo G, Colasanti M et al (2010) Interleukin-1beta induces ceruloplasmin and ferroportin-1 gene expression via MAP kinases and C/EBPbeta, AP-1, and NF-kappaB activation. Neurosci Lett 484:133-138
56. Eun DW, Ahn SH, You JS, Park JW, Lee EK et al (2007) PKCepsilon is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells. Biochem Biophys Res Commun 354:769-775 (Pubitemid 46186252)
57. Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS et al (2011) Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. Gynecol Oncol 120:10
58. Ni XG, Zhou L, Wang GQ, Liu SM, Bai XF et al (2008) The ubiquitin-proteasome pathway mediates gelsolin protein downregulation in pancreatic cancer. Mol Med 14:582-589
59. Li R, Chen WC, Pang XQ, Hua C, Li L et al (2009) Expression of CD40 and CD40L in gastric cancer tissue and its clinical significance. Int J Mol Sci 10:3900-3917